Cargando…

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study

SIMPLE SUMMARY: In this multicentre study of 1117 patients with stage I–IV non-squamous non-small cell lung carcinoma (NSCLC), we investigated associations between KRAS and clinical characteristics and survival. We investigated survival among the following groups of patients: those with no KRAS muta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahl, Sissel Gyrid Freim, Dai, Hong Yan, Emdal, Elisabeth Fritzke, Berg, Thomas, Halvorsen, Tarje Onsøien, Ottestad, Anine Larsen, Lund-Iversen, Marius, Brustugun, Odd Terje, Førde, Dagny, Paulsen, Erna-Elise, Donnem, Tom, Andersen, Sigve, Grønberg, Bjørn Henning, Richardsen, Elin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428342/ https://www.ncbi.nlm.nih.gov/pubmed/34503114 http://dx.doi.org/10.3390/cancers13174294

Ejemplares similares

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
por: Nilssen, Yngvar, et al.
Publicado: (2023)

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
por: Ottestad, Anine Larsen, et al.
Publicado: (2022)

The undifferentiated carcinoma that became a melanoma: Re-biopsy of a cancer of an unknown primary site: a case report
por: Røe, Oluf Dimitri, et al.
Publicado: (2017)

Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
por: Halvorsen, Tarje Onsøien, et al.
Publicado: (2020)

Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
por: Graabak, Gustav, et al.
Publicado: (2021)

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
por: Palmieri, Maria, et al.
Publicado: (2022)

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
por: Tøndell, Anders, et al.
Publicado: (2019)

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions
por: Tøndell, Anders, et al.
Publicado: (2021)

Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC
por: Stokke, Kristin, et al.
Publicado: (2022)

Identification of exercise‐regulated genes in mice exposed to cigarette smoke
por: Aakerøy, Lars, et al.
Publicado: (2022)

A NOTCH added to metabolomics
por: Brustugun, Odd Terje
Publicado: (2019)

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
por: Paulsen, Erna-Elise, et al.
Publicado: (2017)

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
por: Rakaee, Mehrdad, et al.
Publicado: (2016)

NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors
por: McGowan, Marc, et al.
Publicado: (2017)

Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
por: Jiang, Lin, et al.
Publicado: (2021)

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
por: Öjlert, Åsa Kristina, et al.
Publicado: (2019)

NUT expression in primary lung tumours
por: Lund-Iversen, Marius, et al.
Publicado: (2015)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry()
por: Rakaee, Mehrdad, et al.
Publicado: (2019)

A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
por: Skjefstad, Kaja, et al.
Publicado: (2018)

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
por: Ness, Nora, et al.
Publicado: (2017)

Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses
por: Turzer, Martin, et al.
Publicado: (2010)

Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
por: Halvorsen, Ann Rita, et al.
Publicado: (2020)

Norwegian general practitioners’ collaboration with municipal care providers – a qualitative study of structural conditions
por: Steihaug, Sissel, et al.
Publicado: (2017)

Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
por: Grønberg, Bjørn H., et al.
Publicado: (2019)

Osteopontin is a prognostic biomarker in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2013)

CD45RO(+) Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer()
por: Paulsen, Erna-Elise, et al.
Publicado: (2015)

Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer
por: Nordgård, Oddmund, et al.
Publicado: (2013)

Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC
por: Halvorsen, Ann Rita, et al.
Publicado: (2019)

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
por: Horndalsveen, Henrik, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy Is Effective and Safe in Patients with Early-Stage Non-Small Cell Lung Cancer with Low Performance Status and Severe Comorbidity
por: Turzer, Martin, et al.
Publicado: (2011)

Challenges in Achieving Collaboration in Clinical Practice: The Case of Norwegian Health Care
por: Steihaug, Sissel, et al.
Publicado: (2016)

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2012)

Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
por: Kilvaer, Thomas K, et al.
Publicado: (2020)

Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022)

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
por: Berg, Janna, et al.
Publicado: (2021)

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease
por: Berg, Janna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gvqjkha9900jd3sor4e62gmfgj